Anna C. Ferrari

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ferrari_Anna_MD_420x504.jpg

First Name

Anna

Last Name

Ferrari

NPI

1316948268

Faculty ID

16250

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

114467

Is Open Scheduling

Off

Avi Israel Einzig

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/09cad7e0-3cad-11ec-9e23-c5d5559390c7.jpg

First Name

Avi

Last Name

Einzig

NPI

1245311414

Faculty ID

5725

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3261

Is Open Scheduling

Off

Jennifer G. Davila

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/b6cb4d40-5ef8-11ec-a8ce-d9da2e730b48.jpg

First Name

Jennifer

Last Name

Davila

NPI

1417265331

Faculty ID

14331

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Diagnosis and management of children with thrombosis, hemophilia and rare bleeding disorders.

Research Focus

Her primary areas of academic interest include quality improvement efforts to improve thrombosis risk assessment in the pediatric population, specifically elucidating the thrombosis risk in patients with sickle cell disease.

Elsevier Profile

EMR ID

68832

Biography

<p>Jennifer G. Davila, MD, is Co-Director, Hemophilia Treatment Center at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Davila focuses on the care of children with bleeding and clotting disorders.</p><p>After obtaining her Bachelor of Science in psychobiology from the State University of New York at Binghamton in 2000, Dr. Davila earned her Doctor of Medicine at Ross University School of Medicine in 2007. She completed her pediatrics internship and residency at the State University of New York Downstate Medical Center in 2010. Dr. Davila continued her medical training at Memorial Sloan Kettering Cancer Center/Weill-Cornell Medical College, completing a pediatric hematology/oncology fellowship in 2013 where she was Chief Fellow in her final year. She also completed a research fellowship at the same institution in 2014.</p><p>Dr. Davila's research focuses on thrombosis prevention in children. She has been primary investigator and co-primary investigator on funded research projects, and has shared her work through numerous peer-reviewed publications and presentations.</p><p>Dr. Davila is board certified by the American Board of Pediatrics in General Pediatrics and Pediatric Hematology Oncology. She is a member of several professional organizations, including the American Society of Hematology, the Hemostasis and Thrombosis Research Society and the American Society of Clinical Oncology, among others. She sits on the board of the American Thrombosis and Hemostasis Network, is co-chair of the Pediatric sub-committee of the Venous Thromboembolism Network of the United States and is a member of the Medical and Scientific Advisory Council of the National Bleeding Disorders Foundation.</p>

Is Open Scheduling

Off

Susanna Curtis

https://assets.montefioreeinstein.org/profiles/images/16593-susanna-curtis.jpg

First Name

Susanna

Last Name

Curtis

NPI

1154683449

Faculty ID

16593

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Titles

Locations

Education and Trainings

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Is Open Scheduling

Off

Mark H. Chaitowitz

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Mark

Last Name

Chaitowitz

NPI

1922215680

Faculty ID

14005

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Mark Chaitowitz obtained his medical degree at the University of Witwatersrand in Johannesburg, South Africa. He relocated to the United States in 2001, where he completed his residency in internal medicine at Albert Einstein Medical Center, and fellowship in hematology and oncology at Thomas Jefferson University Hospital, both in Philadelphia.</p>
<p>In 2013 Dr. Chaitowitz joined the Division of Hematology as an Assistant Professor. He sees patients with a wide range of blood disorders, both benign and malignant. He has a special interest in platelet disorders, as well as in the management of iron deficiency anemia, his area of clinical research.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<ol>
<li>Zheng, C. Y. Minniti, C. P. Chaitowitz, M. H., Sickle cell crisis complicated by synthetic cannabinoid abuse: a case report, Hemoglobin, 2016, accepted for publication.</li>
<li>Scott, E., U. Borate, S. Heitner, M. Chaitowitz, W. Tester, and G. Eiger, Pain Management Practices by Internal Medicine Residents: A Comparison Before and After Educational and Institutional Interventions, American Journal of Hospice and Palliative Medicine, 2009; 25(6): 431-439.&nbsp;</li>
<li>Chaitowitz, M. H., A. Ferber and N. Flomenberg, Patient-reported experience of chemotherapy: expectations vs. reality, Journal of Clinical Oncology, 2008; 26 (May 20 suppl; abstr 20686).</li>
<li>Darabi, K. Sieber, M. Chaitowitz, M. Braitman, L. Tester, W. Diehl, V. Infradiaphragmatic versus supradiaphragmatic Hodgkin lymphoma: A retrospective review of 1,114 patients. Leukemia and Lymphoma, 2005; 46(12): 1715-1720.&nbsp;</li>
<li>Chaitowitz, M., W. Tester and G. Eiger, Use of a comprehensive survey as a first step in addressing clinical competence of physicians-in-training in the management of pain, Journal of Opioid Management, 2005 May/June; 98-108.</li>
<li>Chaitowitz, M., M.L. Shaw and T.R. Mokoena, Gastrointestinal cryptococcosis presenting as spontaneous jejunal perforation in a nonimmunocompromised host, Digestive Disease and Science, 2003; 48(6): 1196-1199.</li>
</ol>

EMR ID

5733

Is Open Scheduling

Off

Enrico Castellucci

https://assets.montefioreeinstein.org/profiles/images/physphoto/Castellucci_Enrico_MD_420x504.jpg

First Name

Enrico

Last Name

Castellucci

NPI

1821354622

Faculty ID

17784

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

76764

Is Open Scheduling

Off

Jesus D. Anampa Mesias

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f27dbf80-2ee1-11ed-bcda-4d15024a9ee0.jpg

First Name

Jesus

Last Name

Anampa Mesias

NPI

1356590772

Faculty ID

14446

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Jesus Anampa is an Associate Professor of Medicine in the Department of Medical Oncology at Albert Einstein College of Medicine/ Montefiore Medical Center. Dr. Anampa is the Clinical Research Leader for Breast Oncology at Montefiore Medical Center and The Phase I Liaison for Breast Oncology.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">A native of Peru, Dr. Anampa finished medical school at Universidad Peruana Cayetano Heredia in Lima, Peru, and successfully finished Internal Medicine Residency at Rochester General Hospital in Rochester, NY. Dr. Anampa initially joined Albert Einstein College of Medicine/Montefiore Medical Center to complete his fellowship in hematology/oncology and then joined our medical oncology faculty team at AECOM/MMC. In 2018, he obtained a Master&rsquo;s of Science degree &ldquo;with distinction&rdquo; in clinical research from Albert Einstein College of Medicine. Dr. Anampa is a practicing physician who specializes in breast medical oncology and clinical &amp; translational cancer research.&nbsp;</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Tumor MicroEnvironment of Metastasis</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is currently working with the tumor microenvironment (TME) program at Albert Einstein College of Medicine, which is a nationwide well-recognized program, lead by Dr. John Condeelis, evaluating new mechanisms of cancer intravasation and dissemination. Dr. Anampa plays an important role in translating bench-to-bedside and bedside-to-bench research in our TME program, and currently, he is working on the Tumor microenvironment of metastasis (TMEM) and its significance as a biomarker in breast cancer. Dr. Anampa is the principal investigator of a novel phase I trial targeting the tumor microenvironment to prevent metastasis. In addition, Dr. Anampa is leading a clinical trial to validate a novel imaging technique to identify metastasis doorways (TMEM) in vivo using MRI in patients with breast cancer.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT03694756">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT02824575">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Breast Cancer and Obesity</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is working with the diabetes center at Albert Einstein to identify pathways associated with obesity and breast cancer. Preclinical studies at our institution have demonstrated that the CDK4/6-Rb pathway is affected in diet-induced obesity in mouse models. Dr. Anampa is leading a clinical trial that assesses the effect of CDK 4/6 inhibitors on body composition in patients with metastatic breast cancer.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT03697577">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Clinical/Translational Research Leadership</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is The Clinical Research Leader for Breast Oncology at Montefiore Medical Center/AECOM and he serves as local principal investigator for several Phase I, II, and III trials. In addition, Dr. Anampa is also a member of the Protocol Review and monitoring committee at Montefiore Medical Center/AECOM.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa serves as the Montefiore Principal Investigator for the Translational Breast Cancer Research symposium (TBCRC) and the (I-Spy2)</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is a native Spanish-speaker and has an innate passion for breast cancer research, with an ultimate goal to expand breast cancer therapeutic options and improve breast cancer outcomes. Dr. Anampa is also interested in breast cancer research and is always eager to participate in community activities related to breast cancer.</span></p>
<p>&nbsp;</p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">During his free time, Dr. Anampa enjoys mountain biking and soccer.</span></p>

Research Areas

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<p>Dr. Anampa is a breast medical oncologist and a member of the Tumor Microenvironment and Metastasis (TMEM) research program at Albert Einstein College of Medicine, which focuses on targeting the tumor microenvironment as a mechanism to prevent the spread of breast cancer.
He is fluent in Spanish and enjoys participating in bilingual community activities about cancer prevention and treatment in the Bronx.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Breast cancer, medical oncology, clinical trials

Research Focus

Tumor micro-environment of metastasis and breast cancer; breast cancer immunology, new mechanisms of metastasis, cancer among minorities, breast cancer risk and outcomes among women with HIV

Elsevier Profile

EMR ID

56774

Biography

<p>Jesus Anampa Mesias, MD is a medical oncologist at Montefiore Einstein Comprehensive Cancer Center and a member of its Cancer Therapeutics Research Program focused on identifying new treatment targets and novel cancer therapeutics. He is fluent in Spanish and enjoys participating in bilingual community activities about cancer prevention and treatment in our community.</p><p>Dr. Anampa Mesias received his medical degree from the Universidad Peruana Cayetano Heredia in Lima, Peru, completed his residency in internal medicine at Rochester General Hospital in Rochester, NY, and completed a medical oncology/clinical hematology fellowship at Montefiore Medical Center. He remained at Albert Einstein as a research fellow before joining the medical oncology team at Montefiore.</p><p> </p>

Is Open Scheduling

Off